These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4501837)

  • 21. The serological properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1983 Jul; 129(7):2199-206. PubMed ID: 6415227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nature of the antibody response to Yersinia enterocolitica serotype IX in cattle.
    Corbel MJ
    J Hyg (Lond); 1973 Jun; 71(2):309-23. PubMed ID: 4198202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the efficacy of cholera vaccination in a population sample of Bari].
    Barbuti S; Iandolo E; Leogrande G; Rizzo G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):489-99. PubMed ID: 1230049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Biological and chemical investigations of lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX.
    Hurvell B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb; 81(1):105-12. PubMed ID: 4199585
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological cross-reaction between Yersinia enterocolitica O9 and non-O1 Vibrio cholerae bio-serogroup Hakata and antigenic analysis of their relationship by their lipopolysaccharides.
    Isshiki Y; Haishima Y; Kondo S; Shimada T; Hisatsune K
    Microbiol Immunol; 1992; 36(6):575-81. PubMed ID: 1381806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human serum antibodies against heat-stable antigens from Yersinia enterocolitica.
    Maeland JA; Digranes A
    Acta Pathol Microbiol Scand B; 1975 Oct; 83(5):451-6. PubMed ID: 1180060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A microagglutination test for Yersinia enterocolitica infection: recognition of multiple serotypes in experiments with stained suspensions of serotype O5,27.
    Ricciardi ID; Pearson AD; Suckling WG; Klein C
    J Med Microbiol; 1978 Aug; 11(3):359-64. PubMed ID: 98635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
    Benenson AS; Saad A; Mosley WH
    Bull World Health Organ; 1968; 38(2):277-85. PubMed ID: 5302303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.
    Karlsson SL; Ax E; Nygren E; Källgård S; Blomquist M; Ekman A; Benktander J; Holmgren J; Lebens M
    PLoS One; 2014; 9(11):e108521. PubMed ID: 25397871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
    Rastawicki W
    Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.
    Dalby T; Rasmussen E; Schiellerup P; Krogfelt KA
    BMC Microbiol; 2017 May; 17(1):125. PubMed ID: 28545413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective antigens from El Tor vibrios. 1. The preparation and properties of a purified protective antigen from an El Tor vibrio (Ogawa subtype).
    Watanabe Y; Verwey WF
    Bull World Health Organ; 1965; 32(6):809-21. PubMed ID: 5294306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX.
    Hurvell B; Lindberg AA
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb; 81(1):113-9. PubMed ID: 4125692
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study by immunofluorescence of somatic antigens of Yersinia enterocolitica].
    Fribourg-Blanc A
    Ann Biol Clin (Paris); 1971; 29(3):263-70. PubMed ID: 4935393
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity of agglutinating and vibriocidal antibodies to 2-mercaptoethanol in human cholera.
    Merritt CB; Sack RB
    J Infect Dis; 1970 May; 121():Suppl 121:25+. PubMed ID: 4912070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.